Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Rockwell Automation (ROK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Rockwell Automation — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.5 (market cap $31.07B), while Rockwell Automation trades at $419.58 (market cap $48.01B). The key difference: Rockwell Automation is the larger of the two by market cap, and Rockwell Automation pays the higher dividend (1.28%). Which is the better fit depends on your goals.
| GEHC | ROK | |
|---|---|---|
Market Cap | $31.07B | $48.01B |
Volume | 3,443,020 | 919,883 |
Sector | Health | Industrials |
52-Week High | $88.16 | $495.08 |
52-Week Low | $59.48 | $347.66 |
Enterprise Value | $39.53B | $51.14B |
Dividend Yield | 0.23% | 1.28% |
Typical Hold Time | — | 74 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Rockwell Automation (ROK) trades at $423.42, down 2.43% amid bearish technical signals, though it maintains strong profitability with 34.47% ROE and has beaten earnings estimates for three consecutive quarters. The company shows robust cash flow generation of $1.54B from operations in 2025 and continues to lead in industrial automation with recent partnerships in AI cybersecurity and biotech automation.
While valuation multiples appear elevated with a P/E of 40.48, analyst consensus targets $489.89 offering 16% upside potential. Key risks include cyclical industrial demand and margin pressure, but the company's strategic positioning in digital transformation provides long-term growth catalysts for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Rockwell Automation
Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.
Read more on ROK →
